Peroxisome proliferator-activated receptor β activation promotes myonuclear accretion in skeletal muscle of adult and aged mice

被引:25
|
作者
Giordano, C. [1 ]
Rousseau, A. S. [1 ]
Wagner, N. [1 ]
Gaudel, C. [1 ]
Murdaca, J. [1 ]
Jehl-Pietri, C. [1 ]
Sibille, B. [1 ]
Grimaldi, P. A. [1 ]
Lopez, P. [1 ]
机构
[1] Univ Nice Sophia Antipolis, Fac Med, INSERM, U907, F-06107 Nice, France
来源
关键词
Skeletal muscle fibre; Myoblasts; Myogenic response; Muscle plasticity; Calcineurin; SATELLITE CELL-PROLIFERATION; DELTA PPAR-DELTA; MYOGENIC CELLS; FIBER SIZE; REGENERATION; NUMBER; HYPERTROPHY; METABOLISM; EXPRESSION; FUSION;
D O I
10.1007/s00424-009-0676-9
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
We reported recently that peroxisome proliferator-activated receptor beta (PPAR beta) activation promotes a calcineurin-dependent exercise-like remodelling characterised by increased numbers of oxidative fibres and capillaries. As physical exercise also induces myonuclear accretion, we investigated whether PPAR beta activation alters myonuclear density. Transgenic muscle-specific PPAR beta over-expression induced 14% increase of myonuclear density. Pharmacological PPAR beta activation promoted rapid and massive myonuclear accretion (20% increase after 48 h), which is dependent upon calcineurin/nuclear factor of activated T cells signalling pathway. In vivo bromodeoxyuridine labelling and proliferating cell nuclear antigen immunodetection revealed that PPAR beta activation did not promote cell proliferation, suggesting that the PPAR beta-promoted myonuclear accretion involves fusion of pre-existing muscle precursor cells to myofibres rather than cell division. Finally, we showed that in skeletal muscle, ageing led to a down-regulation of PPAR beta accompanied by decrease of both oxidative fibre number and myonuclear density. PPAR beta pharmacological activation counteracts, at least in part, the ageing-driven muscle remodelling.
引用
收藏
页码:901 / 913
页数:13
相关论文
共 50 条
  • [1] Peroxisome proliferator-activated receptor β activation promotes myonuclear accretion in skeletal muscle of adult and aged mice
    C. Giordano
    A. S. Rousseau
    N. Wagner
    C. Gaudel
    J. Murdaca
    C. Jehl-Piétri
    B. Sibille
    P. A. Grimaldi
    P. Lopez
    Pflügers Archiv - European Journal of Physiology, 2009, 458 : 901 - 913
  • [2] Roles of Peroxisome Proliferator-Activated Receptor β/δ in skeletal muscle physiology
    Manickam, Ravikumar
    Wahli, Walter
    BIOCHIMIE, 2017, 136 : 42 - 48
  • [3] Metabolic Functions of Peroxisome Proliferator-Activated Receptor β/δ in Skeletal Muscle
    Gaudel, Celine
    Grimaldi, Paul A.
    PPAR RESEARCH, 2007, 2007
  • [4] Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD
    Remels, A. H.
    Schrauwen, P.
    Broekhuizen, R.
    Willems, J.
    Kersten, S.
    Gosker, H. R.
    Schols, A. M.
    EUROPEAN RESPIRATORY JOURNAL, 2007, 30 (02) : 245 - 252
  • [5] Roles of peroxisome proliferator-activated receptor δ in skeletal muscle function and adaptation
    Fredenrich, A
    Grimaldi, PA
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2004, 7 (04): : 377 - 381
  • [6] Regulation of Skeletal Muscle Physiology and Metabolism by Peroxisome Proliferator-Activated Receptor δ
    Ehrenborg, Ewa
    Krook, Anna
    PHARMACOLOGICAL REVIEWS, 2009, 61 (03) : 373 - 393
  • [7] ENANTIOSELECTIVE ACTIVATION OF THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR
    BOIE, Y
    ADAM, M
    RUSHMORE, TH
    KENNEDY, BP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (08) : 5530 - 5534
  • [8] Telmisartan Improves Insulin Resistance of Skeletal Muscle Through Peroxisome Proliferator-Activated Receptor-δ Activation
    Li, Li
    Luo, Zhidan
    Yu, Hao
    Feng, Xiaoli
    Wang, Peijian
    Chen, Jian
    Pu, Yunfei
    Zhao, Yu
    He, Hongbo
    Zhong, Jian
    Liu, Daoyan
    Zhu, Zhiming
    DIABETES, 2013, 62 (03) : 762 - 774
  • [9] The skeletal muscle peroxisome proliferator-activated receptor α (PPARα) pathway influences the insulin resistant phenotype in mice
    Finck, BN
    Bernal-Mizrachi, C
    Lariviere, LL
    Semenkovich, CF
    Kelly, DP
    DIABETES, 2004, 53 : A333 - A333
  • [10] Mode of Peroxisome Proliferator-Activated Receptor γ Activation by Luteolin
    Puhl, Ana C.
    Bernardes, Amanda
    Silveira, Rodrigo L.
    Yuan, Jing
    Campos, Jessica L. O.
    Saidemberg, Daniel M.
    Palma, Mario S.
    Cvoro, Aleksandra
    Ayers, Stephen D.
    Webb, Paul
    Reinach, Peter S.
    Skaf, Munir S.
    Polikarpov, Igor
    MOLECULAR PHARMACOLOGY, 2012, 81 (06) : 788 - 799